Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.95 USD | +2.34% |
|
-5.15% | +50.90% |
06-11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
05-29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.90% | 963M | |
+15.71% | 121B | |
+18.32% | 112B | |
+4.43% | 22.57B | |
-18.13% | 20.82B | |
-14.73% | 16.3B | |
-16.61% | 16.19B | |
-43.53% | 16.17B | |
+2.47% | 13.17B | |
+24.43% | 11.11B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- TD Cowen Starts Enliven Therapeutics at Outperform